Nebenwirkungen · Ibandronic Acid Teva
Ibandronic Acid Teva 150 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 20
HOS-212608 · Präparat HOS-154930
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-08-28T16:00:09Z · SHA-256 a77d86843d2ecd9a9cc76a7966a88b66429aafa008e6f882df206e72867ec593 · Passage 42f7144177697b690f59b1bda795c3fd216297691cf296a2e1269a137feab3cd · Zeichen 6675–7030 im Abschnitt